Provided by Tiger Fintech (Singapore) Pte. Ltd.

Quest Diagnostics

189.51
+2.691.44%
Post-market: 189.510.00000.00%17:02 EDT
Volume:983.92K
Turnover:186.23M
Market Cap:21.19B
PE:22.71
High:190.08
Open:187.61
Low:187.05
Close:186.82
52wk High:191.49
52wk Low:146.91
Shares:111.82M
Float Shares:111.23M
Volume Ratio:1.12
T/O Rate:0.88%
Dividend:3.10
Dividend Rate:1.64%
EPS(TTM):8.35
EPS(LYR):7.80
ROE:14.26%
ROA:6.34%
PB:2.93
PE(LYR):24.29

Loading ...

Quest Diagnostics Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
12 hours ago

Quest Diagnostics Is Maintained at Neutral by UBS

Dow Jones
·
Yesterday

Mizuho Adjusts Price Target on Quest Diagnostics to $210 From $190, Maintains Outperform Rating

MT Newswires Live
·
Yesterday

UBS Sticks to Its Hold Rating for Quest Diagnostics (DGX)

TIPRANKS
·
Yesterday

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Oct 16

Quest Diagnostics Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Oct 15

Musk Receives AI Supercomputer DGX Spark Hand-Delivered by Jensen Huang

Deep News
·
Oct 14

NVIDIA DGX Spark Arrives for World’s AI Developers

GlobeNewswire
·
Oct 14

A high bar for earnings means the market reaction may be 'varied and violent,' says Evercore. Here's what to do.

Dow Jones
·
Oct 13

Quest Diagnostics Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Oct 11

Robert W. Baird Sticks to Their Hold Rating for Quest Diagnostics (DGX)

TIPRANKS
·
Oct 09

DaVita Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
Oct 09

Quest Diagnostics Is Maintained at In-Line by Evercore ISI Group

Dow Jones
·
Oct 08

Leerink Partners Adjusts Price Target on Quest Diagnostics to $203 From $192, Maintains Outperform Rating

MT Newswires Live
·
Oct 08

Quest Diagnostics price target raised to $190 from $185 at Evercore ISI

TIPRANKS
·
Oct 08

Quest Diagnostics Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Oct 08

Nyse Order Imbalance 56658.0 Shares on Sell Side

THOMSON REUTERS
·
Oct 08

Quest Diagnostics Is Maintained at Equal-Weight by Barclays

Dow Jones
·
Oct 02

Barclays Adjusts Price Target on Quest Diagnostics to $190 From $185, Maintains Equalweight Rating

MT Newswires Live
·
Oct 02

Quest Diagnostics Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
Oct 02